ADIL Adial Pharmaceuticals, Inc.
Healthcare$2.08-9.57%ClosedMarket Cap: $2.0M
As of 2026-05-25
Insider Statistics (Q4 2024)
Acquisitions
2
Dispositions
0
Buy/Sell Ratio
0.00
Net Shares
+390,000
Shares Acquired
390,000
Shares Disposed
0
Total Bought ($)
$0.00
Total Sold ($)
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Thu Apr 09 | Shah Vinay | officer: Chief Financial Officer | Sell | 17,325 | $0.00 | 17,325 |
| Thu Apr 09 | Schuyler Kevin | director | Sell | 9,185 | $0.00 | 9,213 |
| Thu Apr 09 | Goodman Tony | director, officer: Chief Operating Officer | Sell | 26,510 | $0.00 | 26,523 |
| Thu Apr 09 | Gilliland Robertson H. | director | Sell | 9,185 | $0.00 | 9,185 |
| Thu Apr 09 | Claiborne Cary J | director, officer: Chief Executive Officer | Sell | 37,985 | $0.00 | 40,417 |
| Thu Apr 09 | Anderson J. Kermit | director | Sell | 9,185 | $1.64 | 9,185 |
| Mon Jun 02 | Shah Vinay | officer: Chief Financial Officer | Sell | 9,000 | $0.69 | 9,000 |
| Mon Jun 02 | Schuyler Kevin | director | Sell | 28,000 | $0.69 | 28,000 |
| Mon Jun 02 | Newman James W. Jr. | director | Sell | 28,000 | $0.69 | 28,000 |
| Mon Jun 02 | Goodman Tony | director, officer: Chief Operating Officer | Sell | 94,000 | $0.69 | 94,000 |
| Mon Jun 02 | Gilliland Robertson H. | director | Sell | 28,000 | $0.69 | 28,000 |
| Mon Jun 02 | Claiborne Cary J | director, officer: Chief Executive Officer | Sell | 138,000 | $0.69 | 138,000 |
| Mon Jun 02 | Anderson J. Kermit | director | Sell | 28,000 | $0.69 | 28,000 |
| Thu Dec 05 | Claiborne Cary J | director, officer: Chief Executive Officer | Sell | 350,000 | $1.15 | 350,000 |
| Mon Nov 18 | Shah Vinay | officer: Chief Financial Officer | Sell | 40,000 | $1.06 | 40,000 |